Kyverna Therapeutics, Inc.

Symbol
KYTX on Nasdaq
Entity
Company
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
5980 Horton Street, Suite 550, 94608 Emeryville, CA
Phone
5106268331
State of incorporation
DE
Fiscal year end
December 31
Category

Emerging growth company
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Kyverna Therapeutics, Inc. has filed 121 SEC EDGAR filings since 10/5/2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open Document Open Filing Nov 17, 2025 005-94441
10-Q Open Document | Data Open Filing 10-Q Nov 12, 2025 Sep 30, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Nov 12, 2025 Nov 12, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Nov 3, 2025 Nov 2, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Oct 29, 2025 Oct 29, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Oct 29, 2025 Oct 29, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Sep 25, 2025 Sep 19, 2025 001-41947
10-Q Open Document | Data Open Filing 10-Q Aug 12, 2025 Jun 30, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Aug 12, 2025 Aug 12, 2025 001-41947
4 Open Document Open Filing 4 Jul 1, 2025 Jun 30, 2025
3 Open Document Open Filing 3 Jul 1, 2025 Jun 30, 2025
8-K Open Document | Data Open Filing CURRENT REPORT Jun 30, 2025 Jun 30, 2025 001-41947
8-K Open Document | Data Open Filing 8-K Jun 3, 2025 May 29, 2025 001-41947
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
4 Open Document Open Filing 4 Jun 2, 2025 May 29, 2025
10-Q Open Document | Data Open Filing 10-Q May 13, 2025 Mar 31, 2025 001-41947
8-K Open Document | Data Open Filing 8-K May 13, 2025 May 13, 2025 001-41947
EFFECT Open Document Open Filing Apr 15, 2025 333-286180
4 Open Document Open Filing 4 Apr 15, 2025 Apr 11, 2025
4 Open Document Open Filing 4 Apr 15, 2025 Apr 11, 2025
4 Open Document Open Filing 4 Apr 15, 2025 Apr 11, 2025
424B5 Open Document Open Filing 424B5 Apr 15, 2025 333-286180
ARS Open Document Open Filing ARS Apr 14, 2025 Dec 31, 2024 001-41947
DEFA14A Open Document Open Filing DEFA14A Apr 14, 2025 001-41947
DEF 14A Open Document | Data Open Filing DEF 14A Apr 14, 2025 May 29, 2025 001-41947
CORRESP Open Document Open Filing Apr 11, 2025
UPLOAD Open Document Open Filing Apr 1, 2025 333-286180
8-K Open Document | Data Open Filing 8-K Mar 27, 2025 Mar 27, 2025 001-41947
S-8 Open Document Open Filing S-8 Mar 27, 2025 333-286181
S-3 Open Document Open Filing S-3 Mar 27, 2025 333-286180
10-K Open Document | Data Open Filing 10-K Mar 27, 2025 Dec 31, 2024 001-41947
8-K Open Document | Data Open Filing 8-K Mar 27, 2025 Mar 27, 2025 001-41947
4 Open Document Open Filing 4 Feb 19, 2025 Feb 14, 2025
4 Open Document Open Filing 4 Jan 24, 2025 Jan 22, 2025
3 Open Document Open Filing 3 Jan 24, 2025 Jan 22, 2025
8-K Open Document | Data Open Filing 8-K Jan 21, 2025 Jan 21, 2025 001-41947
8-K Open Document | Data Open Filing CURRENT REPORT Jan 13, 2025 Jan 13, 2025 001-41947
S-8 Open Document Open Filing S-8 Nov 26, 2024 333-283489
8-K Open Document | Data Open Filing 8-K Nov 26, 2024 Nov 26, 2024 001-41947
10-Q Open Document | Data Open Filing 10-Q Nov 13, 2024 Sep 30, 2024 001-41947
8-K Open Document | Data Open Filing 8-K Nov 13, 2024 Nov 8, 2024 001-41947
SC 13G Open Document Open Filing SC 13G Nov 12, 2024 005-94441
4 Open Document Open Filing 4 Oct 24, 2024 Oct 21, 2024
3 Open Document Open Filing 3 Oct 24, 2024 Oct 21, 2024
8-K Open Document | Data Open Filing CURRENT REPORT Oct 21, 2024 Oct 20, 2024 001-41947
SC 13G Open Document Open Filing FILING KYVERNA THERAPEUTICS, INC. Oct 10, 2024 005-94441
4 Open Document Open Filing 4 Sep 18, 2024 Sep 16, 2024
4 Open Document Open Filing 4 Sep 18, 2024 Sep 16, 2024
3 Open Document Open Filing 3 Sep 18, 2024 Sep 16, 2024
3 Open Document Open Filing 3 Sep 18, 2024 Sep 16, 2024
8-K Open Document | Data Open Filing CURRENT REPORT Sep 16, 2024 Sep 13, 2024 001-41947
10-Q Open Document | Data Open Filing 10-Q Aug 12, 2024 Jun 30, 2024 001-41947
8-K Open Document | Data Open Filing 8-K Aug 12, 2024 Aug 12, 2024 001-41947
8-K Open Document | Data Open Filing 8-K Jul 15, 2024 Jul 15, 2024 001-41947
UPLOAD Open Document Open Filing Jul 11, 2024 005-94441
8-K Open Document | Data Open Filing 8-K Jun 14, 2024 Jun 14, 2024 001-41947
4 Open Document Open Filing 4 Jun 10, 2024 Jun 6, 2024
4 Open Document Open Filing 4 May 29, 2024 May 28, 2024
10-Q Open Document | Data Open Filing 10-Q May 14, 2024 Mar 31, 2024 001-41947
8-K Open Document | Data Open Filing 8-K May 14, 2024 May 14, 2024 001-41947
SC 13D Open Document Open Filing SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP May 3, 2024 005-94441
10-K Open Document Open Filing 10-K Mar 26, 2024 Dec 31, 2023 001-41947
8-K Open Document Open Filing 8-K Mar 26, 2024 Mar 26, 2024 001-41947
SC 13G Open Document Open Filing SC 13G Feb 22, 2024 005-94441
SC 13G Open Document Open Filing SC 13G Feb 20, 2024 005-94441
4 Open Document Open Filing 4 Feb 14, 2024 Feb 12, 2024
4 Open Document Open Filing 4 Feb 14, 2024 Feb 12, 2024
4 Open Document Open Filing 4 Feb 14, 2024 Feb 12, 2024
4 Open Document Open Filing OWNERSHIP DOCUMENT Feb 14, 2024 Feb 12, 2024
4 Open Document Open Filing 4 Feb 14, 2024 Feb 12, 2024
SC 13G Open Document Open Filing SC 13G Feb 14, 2024 005-94441
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Feb 13, 2024 Feb 12, 2024
SEC STAFF LETTER Open Document Open Filing Feb 13, 2024
4 Open Document Open Filing 4 Feb 12, 2024 Feb 12, 2024
8-K Open Document Open Filing 8-K Feb 12, 2024 Feb 12, 2024 001-41947
S-8 Open Document Open Filing S-8 Feb 8, 2024 333-276952
424B4 Open Document Open Filing 424B4 Feb 8, 2024 333-276523
CERT Open Document Open Filing Feb 8, 2024 001-41947
3 Open Document Open Filing 3 Feb 8, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 8, 2024 Feb 7, 2024
EFFECT Open Document Open Filing Feb 7, 2024 333-276523
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing 3 Feb 7, 2024 Feb 7, 2024
3 Open Document Open Filing INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Feb 7, 2024 Feb 7, 2024
S-1/A Open Document Open Filing S-1/A Feb 6, 2024 333-276523
CORRESP Open Document Open Filing Feb 5, 2024
CORRESP Open Document Open Filing Feb 5, 2024
8-A12B Open Document Open Filing 8-A12B Feb 5, 2024 001-41947
S-1/A Open Document Open Filing S-1/A Feb 1, 2024 333-276523
CORRESP Open Document Open Filing Jan 25, 2024
CORRESP Open Document Open Filing Jan 16, 2024
S-1 Open Document Open Filing S-1 Jan 16, 2024 333-276523
UPLOAD Open Document Open Filing Jan 10, 2024 377-06910
DRS/A Open Document Open Filing Jan 8, 2024 377-06910
DRSLTR Open Document Open Filing Jan 5, 2024
UPLOAD Open Document Open Filing Dec 28, 2023 377-06910
SEC STAFF LETTER Open Document Open Filing Dec 15, 2023
DRSLTR Open Document Open Filing Dec 13, 2023
DRS/A Open Document Open Filing Dec 13, 2023 377-06910
UPLOAD Open Document Open Filing Nov 21, 2023 377-06910
DRSLTR Open Document Open Filing Nov 9, 2023
DRS/A Open Document Open Filing Nov 9, 2023 377-06910
D Open Document Open Filing Nov 7, 2023 021-496597
UPLOAD Open Document Open Filing Nov 1, 2023 377-06910
DRS Open Document Open Filing Oct 5, 2023 377-06910